|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
BNE|XX5837976
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
BNE |
|
005
|
|
|
20190214173418.5 |
|
008
|
|
|
190214n| azznnaabn |n aaa d |
|
035
|
|
|
‡a
(BNE)XX5837976
|
|
010
|
|
|
‡a
XX5837976
|
|
040
|
|
|
‡a
SpMaBN
‡b
spa
‡c
SpMaBN
‡e
rdc
‡f
embne
|
|
100
|
1 |
|
‡a
Portella, Maria Socorro O.
|
|
670
|
|
|
‡a
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the extend study, 2017
‡b
port. (Raymond S.M. Wong, Mansoor N. Saleh, Abderrahim Khelif, Abdulgabar Salama, Maria Socorro O. Portella, Paul Burgess and James B. Bussel)
|
|
910
|
|
|
‡a
safetyandefficacyoflongtermtreatmentofchronicpersistentitpwitheltrombopagfinalresultsoftheextendstudy
‡A
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the extend study
‡l
eng
‡9
1
|
|
921
|
|
|
‡a
springer healthcare iberica s l
‡b
Springer Healthcare Ibérica S.L.,
‡9
1
|
|
922
|
|
|
‡a
sp
‡b
es
‡9
1
|
|
940
|
|
|
‡a
eng
‡9
1
|
|
941
|
|
|
‡a
aut
‡4
aut
‡9
1
|
|
941
|
|
|
‡a
autor
‡e
autor
‡9
1
|
|
943
|
|
|
‡a
201x
‡9
1
|
|
944
|
|
|
‡a
am
‡9
1
|
|
950
|
|
|
‡a
khelif abderrahim
‡A
Khelif, Abderrahim
‡9
1
|
|
950
|
|
|
‡a
salama abdulgabar
‡A
Salama, Abdulgabar
‡9
1
|
|
950
|
|
|
‡a
burgess paul
‡A
Burgess, Paul
‡9
1
|
|
950
|
|
|
‡a
bussel james b
‡A
Bussel, James B.
‡9
1
|
|
950
|
|
|
‡a
saleh mansoor n
‡A
Saleh, Mansoor N.
‡9
1
|
|
950
|
|
|
‡a
wong raymond s m
‡A
Wong, Raymond S. M.
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000445490242
|
|
996
|
|
|
‡2
WKP|Q56722350
|
|
996
|
|
|
‡2
ISNI|0000000060161165
|
|
996
|
|
|
‡2
BLBNB|000325313
|
|
996
|
|
|
‡2
BNC|981058566818406706
|
|
996
|
|
|
‡2
LC|no2015016126
|
|
996
|
|
|
‡2
BLBNB|001119233
|
|
996
|
|
|
‡2
WKP|Q23892655
|
|
996
|
|
|
‡2
WKP|Q41740373
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
999
|
|
|
‡2
BNEBIB|a6423885
|
